Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Konstandin NP"'
Autor:
Pastore F; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Gittinger H; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Raab S; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Tschuri S; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Ksienzyk B; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Konstandin NP; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Schneider S; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Institute of Human Genetics, University Hospital LMU, Munich, Germany., Rothenberg-Thurley M; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Horny HP; Department of Pathology, LMU, Munich, Germany., Werner M; Institute of Surgical Pathology, University of Freiburg, Freiburg, Germany., Sauerland MC; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany., Amler S; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.; Friedrich-Loeffler-Institute, Greifswald-Insel Riems, Germany., Görlich D; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany., Berdel WE; Department of Medicine A, Hematology and Oncology, University of Münster, Münster, Germany., Wörmann B; German Society of Hematology and Oncology, Berlin, Germany., Braess J; Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany., Hiddemann W; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Tischer J; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Herold T; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Center for Environmental Health (HMGU), Munich, Germany., Metzeler KH; Department of Hematology and Cell Therapy, University Hospital Leipzig, Leipzig, Germany., Spiekermann K; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
British journal of haematology [Br J Haematol] 2023 Sep; Vol. 202 (6), pp. 1165-1177. Date of Electronic Publication: 2023 Jul 16.
Autor:
Scheiter A; Institute of Pathology, University of Regensburg, 93053, Regensburg, Germany. Alexander.Scheiter@klinik.uni-regensburg.de.; Bavarian Center for Cancer Research / BZKF, Regensburg, Bavaria, Germany. Alexander.Scheiter@klinik.uni-regensburg.de., Hierl F; Institute of Pathology, University of Regensburg, 93053, Regensburg, Germany., Lüke F; Bavarian Center for Cancer Research / BZKF, Regensburg, Bavaria, Germany.; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, 93053, Regensburg, Germany.; Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM-R, Abteilung für personalisierte Onkologie, 93053, Regensburg, Germany., Keil F; Institute of Pathology, University of Regensburg, 93053, Regensburg, Germany., Heudobler D; Bavarian Center for Cancer Research / BZKF, Regensburg, Bavaria, Germany.; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, 93053, Regensburg, Germany., Einhell S; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, 93053, Regensburg, Germany., Klier-Richter M; Institute of Pathology, University of Regensburg, 93053, Regensburg, Germany., Konstandin NP; Institute of Pathology, University of Regensburg, 93053, Regensburg, Germany.; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, 93053, Regensburg, Germany., Weber F; Institute of Pathology, University of Regensburg, 93053, Regensburg, Germany., Scheiter A; School of Engineering and Design, Chair of Ergonomics, Technical University of Munich, 85748, Garching, Germany., Kandulski A; Department of Internal Medicine I, University Hospital Regensburg, 93053, Regensburg, Germany., Schlosser S; Department of Internal Medicine I, University Hospital Regensburg, 93053, Regensburg, Germany., Cosma LS; Department of Internal Medicine I, University Hospital Regensburg, 93053, Regensburg, Germany., Tews H; Department of Internal Medicine I, University Hospital Regensburg, 93053, Regensburg, Germany., Weiss ARR; Department of Surgery, University Hospital Regensburg, 93053, Regensburg, Germany., Grube M; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, 93053, Regensburg, Germany., Bumes E; Department of Neurology and Wilhelm Sander-NeuroOncology Unit, 93053 Regensburg University Hospital, 93053, Regensburg, Germany., Hau P; Department of Neurology and Wilhelm Sander-NeuroOncology Unit, 93053 Regensburg University Hospital, 93053, Regensburg, Germany., Proescholdt M; Department of Neurosurgery, University Hospital Regensburg, 93053, Regensburg, Germany., Steger F; Department of Radiotherapy, Regensburg University Medical Center, 93053, Regensburg, Germany., Troeger A; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University Hospital of Regensburg, 93053, Regensburg, Germany., Haferkamp S; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany., Reibenspies LE; Institute of Pathology, University of Regensburg, 93053, Regensburg, Germany., Schnabel MJ; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, 93053, Regensburg, Germany., Schulz C; Department of Pneumology, University Hospital Regensburg, 93053, Regensburg, Germany., Drexler K; Department of Dermatology, University Hospital Regensburg, Regensburg, Germany., Hatzipanagiotou ME; University Medical Centre Regensburg, Department of Gynecology and Obstetrics, 93053, Regensburg, Germany., Seitz S; University Medical Centre Regensburg, Department of Gynecology and Obstetrics, 93053, Regensburg, Germany., Klinkhammer-Schalke M; Tumour Center-Institute for Quality Management and Health Services Research, University of Regensburg, 93053, Regensburg, Germany., Unberath P; Friedrich-Alexander University Erlangen-Nuremberg, Chair of Medical Informatics, 91054, Erlangen, Germany., Calvisi DF; Institute of Pathology, University of Regensburg, 93053, Regensburg, Germany., Pukrop T; Bavarian Center for Cancer Research / BZKF, Regensburg, Bavaria, Germany.; Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, 93053, Regensburg, Germany.; Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM-R, Abteilung für personalisierte Onkologie, 93053, Regensburg, Germany., Dietmaier W; Institute of Pathology, University of Regensburg, 93053, Regensburg, Germany., Evert M; Institute of Pathology, University of Regensburg, 93053, Regensburg, Germany., Utpatel K; Institute of Pathology, University of Regensburg, 93053, Regensburg, Germany.
Publikováno v:
British journal of cancer [Br J Cancer] 2023 Apr; Vol. 128 (6), pp. 1134-1147. Date of Electronic Publication: 2022 Dec 26.
Autor:
Herold T; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Research Unit Apoptosis in Hematopoietic Stem Cells, Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Munich, Germany., Rothenberg-Thurley M; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Grunwald VV; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Janke H; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Goerlich D; Institute of Biostatistics and Clinical Research, Westfälische Wilhelms-Universität Münster, Münster, Germany., Sauerland MC; Institute of Biostatistics and Clinical Research, Westfälische Wilhelms-Universität Münster, Münster, Germany., Konstandin NP; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Dufour A; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Schneider S; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Neusser M; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Ksienzyk B; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Greif PA; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Subklewe M; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Faldum A; Institute of Biostatistics and Clinical Research, Westfälische Wilhelms-Universität Münster, Münster, Germany., Bohlander SK; Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand., Braess J; Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany., Wörmann B; Charité University Hospital Berlin, Berlin, Germany., Krug U; Hospital Leverkusen, Leverkusen, Germany., Berdel WE; Department of Medicine A, University Hospital Münster, Münster, Germany., Hiddemann W; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Spiekermann K; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Metzeler KH; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany. klaus.metzeler@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany. klaus.metzeler@med.uni-muenchen.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. klaus.metzeler@med.uni-muenchen.de.
Publikováno v:
Leukemia [Leukemia] 2020 Dec; Vol. 34 (12), pp. 3161-3172. Date of Electronic Publication: 2020 Mar 30.
Autor:
Opatz S; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Experimental Leukemia & Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Bamopoulos SA; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Metzeler KH; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Experimental Leukemia & Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Herold T; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Ksienzyk B; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Bräundl K; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Experimental Leukemia & Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Tschuri S; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Vosberg S; Experimental Leukemia & Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Konstandin NP; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Wang C; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany., Hartmann L; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Experimental Leukemia & Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Graf A; Laboratory for Functional Genome Analysis at the Gene Center, LMU Munich, Munich, Germany., Krebs S; Laboratory for Functional Genome Analysis at the Gene Center, LMU Munich, Munich, Germany., Blum H; Laboratory for Functional Genome Analysis at the Gene Center, LMU Munich, Munich, Germany., Schneider S; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Institute of Human Genetics, University Hospital, LMU Munich, Munich, Germany., Thiede C; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Dresden, Germany., Middeke JM; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Dresden, Germany., Stölzel F; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Dresden, Germany., Röllig C; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Dresden, Germany., Schetelig J; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Dresden, Germany., Ehninger G; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Internal Medicine 1, University Hospital Carl Gustav Carus, Dresden, Germany., Krämer A; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Braess J; Oncology and Hematology, St. John of God Hospital, Regensburg, Germany., Görlich D; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany., Sauerland MC; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany., Berdel WE; Department of Medicine A, Hematology, Oncology and Pneumology, University of Münster, Münster, Germany., Wörmann BJ; Department of Hematology, Oncology and Tumor Immunology, Charité University Medicine, Campus Virchow, Berlin, Germany., Hiddemann W; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Experimental Leukemia & Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Spiekermann K; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; Experimental Leukemia & Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Bohlander SK; Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand., Greif PA; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany. pgreif@med.uni-muenchen.de.; Experimental Leukemia & Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Munich, Germany. pgreif@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Heidelberg, Germany. pgreif@med.uni-muenchen.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. pgreif@med.uni-muenchen.de.
Publikováno v:
Leukemia [Leukemia] 2020 Jun; Vol. 34 (6), pp. 1553-1562. Date of Electronic Publication: 2020 Jan 02.
Autor:
Lichtenegger FS; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; Present address: Roche Innovation Center Munich Penzberg Germany., Schnorfeil FM; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Heidelberg Germany.; Present address: Medigene AG Planegg Germany., Rothe M; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Deiser K; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Altmann T; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Bücklein VL; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Köhnke T; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Augsberger C; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany., Konstandin NP; Department of Medicine III University Hospital, LMU Munich Munich Germany., Spiekermann K; Department of Medicine III University Hospital, LMU Munich Munich Germany., Moosmann A; DZIF Research Group 'Host Control of Viral Latency and Reactivation' (HOCOVLAR) Helmholtz Zentrum München Munich Germany., Boehm S; Max von Pettenkofer Institute LMU Munich Munich Germany., Boxberg M; Institute of Pathology Technical University of Munich Munich Germany., Heemskerk MH; Department of Hematology Leiden University Medical Center Leiden The Netherlands., Goerlich D; Institute of Biostatistics and Clinical Research University of Muenster Muenster Germany., Wittmann G; Department of Transfusion Medicine, Cellular Therapeutics and Hemostaseology University Hospital LMU Munich Munich Germany., Wagner B; Department of Transfusion Medicine, Cellular Therapeutics and Hemostaseology University Hospital LMU Munich Munich Germany., Hiddemann W; Department of Medicine III University Hospital, LMU Munich Munich Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Heidelberg Germany., Schendel DJ; Medigene AG Planegg Germany., Kvalheim G; Department of Cellular Therapy The Norwegian Radium Hospital Oslo University Hospital Oslo Norway., Bigalke I; Department of Cellular Therapy The Norwegian Radium Hospital Oslo University Hospital Oslo Norway.; Present address: BioNTech IMFS Idar-Oberstein Germany., Subklewe M; Department of Medicine III University Hospital, LMU Munich Munich Germany.; Laboratory for Translational Cancer Immunology Gene Center LMU Munich Munich Germany.; German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ) Heidelberg Germany.
Publikováno v:
Clinical & translational immunology [Clin Transl Immunology] 2020 Mar 03; Vol. 9 (3), pp. e1117. Date of Electronic Publication: 2020 Mar 03 (Print Publication: 2020).
Autor:
Vosberg S; Experimental Leukemia and Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany., Hartmann L; Experimental Leukemia and Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany., Metzeler KH; Experimental Leukemia and Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany., Konstandin NP; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany., Schneider S; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany.; Institute of Human Genetics, University Hospital, LMU Munich, Germany., Varadharajan A; Laboratory for Functional Genome Analysis, Gene Center, LMU Munich, Germany., Hauser A; Laboratory for Functional Genome Analysis, Gene Center, LMU Munich, Germany., Krebs S; Laboratory for Functional Genome Analysis, Gene Center, LMU Munich, Germany., Blum H; Laboratory for Functional Genome Analysis, Gene Center, LMU Munich, Germany., Bohlander SK; Leukaemia and Blood Cancer Research Unit, Department of Molecular Medicine and Pathology, The University of Auckland, New Zealand., Hiddemann W; Experimental Leukemia and Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany., Tischer J; Hematopoietic Stem Cell Transplantation, Department of Medicine III, University Hospital, LMU Munich, Germany., Spiekermann K; Experimental Leukemia and Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany., Greif PA; Experimental Leukemia and Lymphoma Research, Department of Medicine III, University Hospital, LMU Munich, Germany pgreif@med.uni-muenchen.de.; German Cancer Consortium (DKTK), partner site Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany.
Publikováno v:
Haematologica [Haematologica] 2018 Dec; Vol. 103 (12), pp. e581-e584. Date of Electronic Publication: 2018 Jun 28.
Autor:
Prassek VV; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany., Rothenberg-Thurley M; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany., Sauerland MC; Institute of Biostatistics and Clinical Research, University of Münster, Germany., Herold T; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Janke H; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany., Ksienzyk B; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany., Konstandin NP; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany., Goerlich D; Institute of Biostatistics and Clinical Research, University of Münster, Germany., Krug U; Hospital Leverkusen, Germany., Faldum A; Institute of Biostatistics and Clinical Research, University of Münster, Germany., Berdel WE; Institute of Biostatistics and Clinical Research, University of Münster, Germany., Wörmann B; Charité - University Hospital Berlin, Germany., Braess J; Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany., Schneider S; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany., Subklewe M; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany., Bohlander SK; Department of Molecular Medicine and Pathology, University of Auckland, New Zealand., Hiddemann W; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Spiekermann K; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Metzeler KH; Laboratory for Leukemia Diagnostics, Department of Medicine III, University Hospital, LMU Munich, Germany klaus.metzeler@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site Munich, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
Haematologica [Haematologica] 2018 Nov; Vol. 103 (11), pp. 1853-1861. Date of Electronic Publication: 2018 Jun 14.
Autor:
Konstandin NP; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilians-Universität, Munich, Germany.; German Cancer Research Center, Heidelberg, Germany.; German Cancer Consortium, Partner Site Munich, Munich, Germany., Pastore F; Department of Internal Medicine III, Ludwig-Maximilians-Universität, Munich, Germany., Herold T; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilians-Universität, Munich, Germany.; German Cancer Research Center, Heidelberg, Germany.; German Cancer Consortium, Partner Site Munich, Munich, Germany., Dufour A; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilians-Universität, Munich, Germany., Rothenberg-Thurley M; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilians-Universität, Munich, Germany., Hinrichsen T; Center for Human Genetics and Laboratory Medicine, Martinsried, Germany., Ksienzyk B; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilians-Universität, Munich, Germany., Tschuri S; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilians-Universität, Munich, Germany.; German Cancer Research Center, Heidelberg, Germany.; German Cancer Consortium, Partner Site Munich, Munich, Germany., Schneider S; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilians-Universität, Munich, Germany., Hoster E; Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany., Berdel WE; Department of Medicine A-Hematology, Oncology and Pneumology, University of Münster, Münster, Germany., Woermann BJ; Division of Hematology, Oncology and Tumor Immunology, Department of Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany., Sauerland MC; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany., Braess J; Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany; and., Bohlander SK; Leukaemia & Blood Cancer Research Unit, Department of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand., Klein HG; Center for Human Genetics and Laboratory Medicine, Martinsried, Germany., Hiddemann W; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilians-Universität, Munich, Germany.; German Cancer Research Center, Heidelberg, Germany.; German Cancer Consortium, Partner Site Munich, Munich, Germany., Metzeler KH; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilians-Universität, Munich, Germany.; German Cancer Research Center, Heidelberg, Germany.; German Cancer Consortium, Partner Site Munich, Munich, Germany., Spiekermann K; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, Ludwig-Maximilians-Universität, Munich, Germany.; German Cancer Research Center, Heidelberg, Germany.; German Cancer Consortium, Partner Site Munich, Munich, Germany.
Publikováno v:
Blood advances [Blood Adv] 2018 Oct 23; Vol. 2 (20), pp. 2724-2731.
Autor:
Rothenberg-Thurley M; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Amler S; Institute of Biostatistics and Clinical Research, WWU Münster, Münster, Germany., Goerlich D; Institute of Biostatistics and Clinical Research, WWU Münster, Münster, Germany., Köhnke T; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, LMU Munich, Munich, Germany., Konstandin NP; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, LMU Munich, Munich, Germany., Schneider S; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, LMU Munich, Munich, Germany., Sauerland MC; Institute of Biostatistics and Clinical Research, WWU Münster, Münster, Germany., Herold T; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, LMU Munich, Munich, Germany., Hubmann M; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, LMU Munich, Munich, Germany., Ksienzyk B; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, LMU Munich, Munich, Germany., Zellmeier E; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, LMU Munich, Munich, Germany., Bohlander SK; Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand., Subklewe M; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Faldum A; Institute of Biostatistics and Clinical Research, WWU Münster, Münster, Germany., Hiddemann W; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Braess J; Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany., Spiekermann K; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany., Metzeler KH; Laboratory for Leukemia Diagnostics, Department of Internal Medicine III, LMU Munich, Munich, Germany. klaus.metzeler@med.uni-muenchen.de.; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany. klaus.metzeler@med.uni-muenchen.de.
Publikováno v:
Leukemia [Leukemia] 2018 Jul; Vol. 32 (7), pp. 1598-1608. Date of Electronic Publication: 2018 Feb 23.
Autor:
Greif PA; Department of Medicine III, University Hospital, LMU Munich, München, Germany. pgreif@med.uni-muenchen.de.; German Cancer Consortium (DKTK), and.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Hartmann L; Department of Medicine III, University Hospital, LMU Munich, München, Germany.; German Cancer Consortium (DKTK), and.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Vosberg S; Department of Medicine III, University Hospital, LMU Munich, München, Germany.; German Cancer Consortium (DKTK), and.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Stief SM; Department of Medicine III, University Hospital, LMU Munich, München, Germany.; German Cancer Consortium (DKTK), and.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Mattes R; Department of Medicine III, University Hospital, LMU Munich, München, Germany.; German Cancer Consortium (DKTK), and.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Hellmann I; Anthropology and Human Genomics, Department Biology II, LMU Munich, Martinsried, Germany., Metzeler KH; Department of Medicine III, University Hospital, LMU Munich, München, Germany.; German Cancer Consortium (DKTK), and.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Herold T; Department of Medicine III, University Hospital, LMU Munich, München, Germany.; German Cancer Consortium (DKTK), and.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Bamopoulos SA; Department of Medicine III, University Hospital, LMU Munich, München, Germany., Kerbs P; Department of Medicine III, University Hospital, LMU Munich, München, Germany.; German Cancer Consortium (DKTK), and.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Jurinovic V; Institute for Medical Information Procesing, Biometry and Epidemiology (IBE), LMU Munich, München, Germany., Schumacher D; Department of Medicine III, University Hospital, LMU Munich, München, Germany.; German Cancer Consortium (DKTK), and.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Pastore F; Department of Medicine III, University Hospital, LMU Munich, München, Germany.; German Cancer Consortium (DKTK), and.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Bräundl K; Department of Medicine III, University Hospital, LMU Munich, München, Germany.; German Cancer Consortium (DKTK), and.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Zellmeier E; Department of Medicine III, University Hospital, LMU Munich, München, Germany., Ksienzyk B; Department of Medicine III, University Hospital, LMU Munich, München, Germany., Konstandin NP; Department of Medicine III, University Hospital, LMU Munich, München, Germany., Schneider S; Department of Medicine III, University Hospital, LMU Munich, München, Germany., Graf A; Laboratory for Functional Genome Analysis (LAFUGA), Gene Center, LMU Munich, München, Germany., Krebs S; Laboratory for Functional Genome Analysis (LAFUGA), Gene Center, LMU Munich, München, Germany., Blum H; Laboratory for Functional Genome Analysis (LAFUGA), Gene Center, LMU Munich, München, Germany., Neumann M; German Cancer Consortium (DKTK), and.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Divison of Hematology and Oncology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, and Campus Virchow, Berlin, Germany., Baldus CD; German Cancer Consortium (DKTK), and.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Divison of Hematology and Oncology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, and Campus Virchow, Berlin, Germany., Bohlander SK; Leukaemia and Blood Cancer Research Unit, Department of Molecular Medicine and Pathology, The University of Auckland, Auckland, New Zealand., Wolf S; German Cancer Research Center (DKFZ), Heidelberg, Germany., Görlich D; Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany., Berdel WE; Department of Medicine A -Hematology, Oncology and Pneumology, University of Münster, Münster, Germany., Wörmann BJ; Divison of Hematology and Oncology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, and Campus Virchow, Berlin, Germany., Hiddemann W; Department of Medicine III, University Hospital, LMU Munich, München, Germany.; German Cancer Consortium (DKTK), and.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Spiekermann K; Department of Medicine III, University Hospital, LMU Munich, München, Germany.; German Cancer Consortium (DKTK), and.; German Cancer Research Center (DKFZ), Heidelberg, Germany.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Apr 01; Vol. 24 (7), pp. 1716-1726. Date of Electronic Publication: 2018 Jan 12.